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Objective: This study was performed to determine how often Japanese women diagnosed as normo-
glycemic on ﬁrst-trimester 75-g glucose tolerance test (75gGTT) later develop gestational diabetes
mellitus (GDM).
Material and methods: Sixty-two womenwith random plasma glucose (PG) level  105 mg/dL during the
ﬁrst trimester and subsequent ﬁrst-trimester diagnosis of normoglycemia with 75gGTT underwent 50-g
glucose challenge test (50gGCT) during the second trimester. Twenty-one with a positive 50gGCT result
(60-m PG  140 mg/dL) underwent second-trimester 75gGTT. First-trimester random PG levels and
75gGTT results were compared between 21 and 41 women with positive and negative 50gGCT results,
respectively. Changes in immunoreactive insulin (IRI) associated with 75gGTT were determined
simultaneously.
Results: All 21 women with a positive 50gGCT result showed normoglycemia on second-trimester
75gGTT. Thus, none of the 62 women developed GDM. Insulin resistance increased signiﬁcantly in the
21 women with 75gGTT during the ﬁrst and second trimesters, as indicated by increases in homeostasis
model assessment for insulin resistance (HOMA-IR) and homeostasis model assessment for b-cell
function (HOMA-b) with no signiﬁcant changes in preload or afterload PG levels. Neither random PG
levels (116 ± 12 vs. 116 ± 12 mg/dL, respectively) nor 75gGTT results (86 ± 6 vs. 84 ± 5 mg/dL for 0-
minute [0-m] PG level, 130 ± 28 vs. 131 ± 25 mg/dL for 60-m PG, and 111 ± 19 vs. 118 ± 18 mg/dL for
120-m PG, respectively) during the ﬁrst trimester differed signiﬁcantly between the 41 and 21 women
with negative and positive second-trimester 50gGCT results, respectively.
Conclusion: Although insulin resistance increased in the second trimester, risk of developing GDM was <
1/62 among Japanese women in whom hyperglycemia was excluded with ﬁrst-trimester GTT.
Copyright © 2016, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
The Japanese guidelines for obstetric practice issued in 2011 [1]
specify that pregnant women should be screened for hyperglyce-
mia in a two-step manner: measurement of random plasma
glucose (PG) level during the ﬁrst trimester and subsequent 75-g
glucose tolerance test (75gGTT) in women with random PGand Gynecology, Hokkaido
oro 060-8638, Japan.
. Morikawa).
bstetrics & Gynecology. Publishedlevel  95 mg/dL,  100 mg/dL, or  105 mg/dL at the facility's
discretion; and measurement of random PG level or 50-g glucose
challenge test (50gGCT) during the second trimester for women not
diagnosed with hyperglycemia in the ﬁrst trimester. Women
exhibiting a second-trimester random PG level  100 mg/dL or a
positive 50gGCT result (60-minute [60-m] PG level  140 mg/dL)
undergo subsequent 75gGTT during the second trimester (at
gestational week [GW] 24e28). Thus, a certain fraction of women
undergo GTT twice during pregnancy in accordance with the
guidelines. [1] However, how often Japanese women with normo-
glycemia on 75gGTT in the ﬁrst trimester are diagnosed as having
GDM based on 50gGCT and subsequent 75gGTT in the secondby Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
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retrospective study to address this issue.
Materials and methods
This study was conducted with the approval of the institutional
review board of Hokkaido University Hospital. Among 1068women
who gave birth at our institution during the period between
January 2009 and December 2012, a total of 77 pregnant women
with a ﬁrst-trimester (GW 10e12) random PG level  105 mg/dL
underwent 75gGTT during the ﬁrst trimester (GW 12e14). Fifteen
(19%) of the 77 women were diagnosed as having hyperglycemia,
including 14 with gestational diabetes mellitus (GDM) and one
with overt diabetes in pregnancy, whereas the remaining 62 (81%)
were diagnosed as normoglycemic based on the criteria adopted in
2010 by the Japan Society of Obstetrics and Gynecology (Figure 1)
[1]; brieﬂy, normoglycemia was diagnosed in women with fasting
PG level < 92 mg/dL (5.1 mmol/L), 60-min PG level < 180 mg/dL
(10.0 mmol/L), and 120-minute (120-m) PG level < 153 mg/dL
(8.5 mmol/L) after 75gGTT. The percentage of women with nor-
moglycemia after ﬁrst-trimester 75gGTT did not differ according to
the ﬁrst-trimester random PG level (Table 1). These 62womenwith
a diagnosis of normoglycemia on ﬁrst-trimester 75gGTT were
included in the present study.
All of the 62 participants included in the study underwent
50gGCT during the second trimester (GW 24e28). Forty-one
women with a negative 50gGCT result (60-m PG level < 140 mg/
dL) were ﬁnally diagnosed as having normoglycemia, and 21
women with a positive 50gGCT result subsequently underwent
75gGTT during the second trimester (GW 24e28). Thus, 21 women
underwent 75gGTT twice during pregnancy.
By using blood samples obtained during the GTT, immunore-
active insulin (IRI) was determined by enzyme immunoassay (EIA)
(Tosoh Inc., Tokyo, Japan). The insulin secretory capacity and the
insulin sensitivity/resistance ratio were assessed using several
indices, including the quantitative insulin sensitivity check index
(QUICKI), [2] the homeostasis model assessment for insulin resis-
tance (HOMA-IR), [3] and the homeostasis model assessment for b-
cell function (HOMA-b). [3].
All data are presented as the means ± SD. The two-sample t-test,
KruskaleWallis test, ManneWhitney U-test, Wilcoxon's test, and
analysis of variance (ANOVA) were used to analyze the results.
Fisher's exact test was used to compare frequencies. In all analyzes,
p < 0.05 was taken to indicate statistical signiﬁcance. The statisticalFigure 1. Flow chart for selection of 62 study participants and subsequent outcomes.
DM ¼ diabetes mellitus; GCT ¼ glucose challenge test; GDM ¼ gestational diabetes
mellitus; GTT ¼ glucose tolerance test; PG ¼ plasma glucose.software package StatView 5.0 for Macintosh (SAS Institute Inc.
Cary, NC) was used for all data analyzes.
Results
None of the 21 womenwith second-trimester 75gGTT showed a
positive test result (Figure 1). Thus, none of the 62 women with a
diagnosis of normoglycemia after the ﬁrst-trimester 75gGTT
developed GDM. Mean birth weight expressed as the standard
deviation (SD) score was 0.174 for 62 infants born to these 62
women and 9.7% of the 62 infants had a birth weight  3500 g
(Table 1).
Comparison of 75gGTT results obtained during the ﬁrst and second
trimesters in 21 women
Twenty-one of the 62 women with a negative 75gGTT result
during the ﬁrst trimester showed a positive test result on the
second-trimester 50gGCT and again underwent 75gGTT during the
second trimester (Table 2). In these 21 women, neither the fasting
PG level 60-m PG level nor 120-m PG level differed signiﬁcantly
between 75gGTT results of the ﬁrst and second trimesters. How-
ever, insulin resistance increased in the second trimester compared
with the ﬁrst trimester: fasting IRI was signiﬁcantly higher for
second-trimester than ﬁrst trimester 75gGTT in the presence of
similar fasting PG level; HOMA-IR and HOMA-b increased signiﬁ-
cantly in the second trimester; and QUIKI decreased signiﬁcantly in
the second trimester.
Comparison of women with positive and negative 50gGCT results
Sixty-twowomenwere divided into two groups according to the
results of 50gGCT performed during the second trimester. There
were no differences between the two groups in random PG levels
determined during the ﬁrst trimester, prepregnancy body mass
index (BMI), rate of cesarean delivery, gestational week at delivery,
infant birth weight, fetal growth, or PG and IRI proﬁles on 75gGTT
performed during the ﬁrst trimester (Table 3).
Discussion
In the present study, none of 62 Japanese women diagnosed as
normoglycemic on 75gGTT during the ﬁrst trimester following
ﬁrst-trimester random PG level  105 mg/dL developed GDM.
However, 21 (34%) of the 62 women exhibited a positive 50gGCT
result performed during the second trimester. There were no dif-
ferences in parameters, such as prepregnancy BMI, infant birth
weight, or proﬁles of PG and IRI on 75gGTT during the ﬁrst
trimester, between the 41 and 21 women with negative and posi-
tive 50gGCT results, respectively. Furthermore, in the 21 women
undergoing 75gGTT twice during ﬁrst and second trimesters, there
were no signiﬁcant differences in fasting PG, 60-m PG, or 120-m PG
levels between the two tests, although insulin resistance increased
in the second trimester compared with the ﬁrst trimester. These
results suggested that, among normoglycemic women on 75gGTT
during the ﬁrst trimester, the 50gGCT during the second trimester
had limited clinical usefulness for detection of GDM.
The International Association of Diabetes and Pregnancy Study
Groups (IADPSG) consensus panel acknowledged that there have
been insufﬁcient studies performed to determine whether there is
a beneﬁt of GTT before the usual window of GW 24e28. [4] Thus, it
has not been determined whether 75gGTT performed during the
ﬁrst trimester is effective for excluding subsequent risk of GDM.
The results of the present study suggested that the absolute risk of
developing GDM was < 1/62 among Japanese women diagnosed
Table 1
Distribution of ﬁrst trimester random glucose level in relation to subsequent 75gGTT results and infant birth weight.
First trimester random glucose level (mg/dL) Result of ﬁrst trimester 75gGTT Infant birth weight * (n ¼ 62)
Normoglycemia GDM/overt diabetes SD score  3500 g
105e109 (n ¼ 32) 26 (81%) 6 (19%) 0.043 ± 1.052 4/26 (15.4%)
110e114 (n ¼ 13) 11 (85%) 2 (15%) 0.422 ± 0.728 0/11 (0.0%)
 115 (n ¼ 32) 25 (78%) 7 (22%) 0.201 ± 1.172 2/25 (8.0%)
Overall (n ¼ 77) 62 (81%) 15 (19%)y 0.174 ± 1.049 6/62 (9.7%)
GDM ¼ gestational diabetes mellitus; GTT ¼ glucose tolerance test; SD ¼ standard deviation.
y After ﬁrst trimester 75gGTT, 15 women diagnosed with hyperglycemia including 14 with gestational diabetes mellitus, and one with overt diabetes in pregnancy were
excluded from the present study.
* Analysis for 62 neonates born to 62 mothers with normoglycemia after excluding 15 neonates born to mothers with hyperglycemia.
Table 2
Comparison of 75gGTT results in 21 women (ﬁrst trimester vs. second trimester).
75gGTT at
ﬁrst trimester
75gGTT at
second trimester
p
Fasting PG 84.1 ± 4.6 84.3 ± 5.5 0.8603
60-min PG 130.5 ± 24.7 138.4 ± 19.9 0.3001
120-min PG 117.7 ± 17.7 120.4 ± 27.1 0.6981
Fasting IRI 6.2 ± 3.6 8.0 ± 4.3 0.0063*
60-min IRI 53.8 ± 28.4 69.0 ± 47.7 0.1803
120-min IRI 51.6 ± 30.4 59.3 ± 36.2 0.4252
AUCPG 231.5 ± 30.2 240.8 ± 24.6 0.2620
AUCIRI 82.7 ± 41.4 102.7 ± 62.4 0.1841
HOMA-IR 1.30 ± 0.77 1.69 ± 0.96 0.0130**
HOMA-b 108.1 ± 62.7 146.6 ± 88.5 0.0037*
QUICKI 0.379 ± 0.033 0.362 ± 0.028 0.0161**
AUCPG/AUCIRI 3.45 ± 1.74 2.88 ± 1.22 0.1917
AUC ¼ area under the curve; GTT ¼ glucose tolerance test; HOMA-b ¼ homeostasis
model assessment for b-cell function; HOMA-IR ¼ homeostasis model assessment
for insulin resistance; IRI ¼ immunoreactive insulin; PG ¼ plasma glucose (mg/dL);
QUICKI ¼ quantitative insulin sensitivity check index.
*p < 0.01.
**p < 0.05.
Table 3
Demographic characteristics and results of GTT performed during ﬁrst trimester
according to results of 50gGCT during second trimester.
60-min PG
< 140 mg/dL  140 mg/dL p
No of women 41 21
PG level at 50gGCT (mg/dL) 114 ± 17 155 ± 16 < 0.0001*
First trimester random PG (mg/dL) 116 ± 12 116 ± 12 0.9583
Prepregnancy BMI (kg/m2) 21.4 ± 2.8 22.6 ± 3.6 0.2678
Cesarean delivery 18 (43.9%) 6 (28.6%) 0.2815
Gestational wk at delivery 38.0 ± 2.4 37.8 ± 2.3 0.7256
< 37 5 (12.2%) 4 (19.0%) 0.4725
Infant birth weight (g) 2869 ± 554 2987 ± 520 0.4938
SD score 0.033 ± 1.160 0.448 ± 0.739 0.1881
 3500 g 3 (7.3%) 3 (14.3%) 0.3981
 4000 g 0 (0.0%) 0 (0.0%) 1.0000
75gGTT at ﬁrst trimester
Fasting PG (mg/dL) 85.8 ± 5.9 84.1 ± 4.6 0.2539
60-min PG (mg/dL) 130.1 ± 27.9 130.5 ± 24.7 0.8408
120-min PG (mg/dL) 111.0 ± 18.9 117.7 ± 17.7 0.1757
Fasting IRI (mU/mL) 5.9 ± 3.3 6.2 ± 3.6 0.8003
60-min IRI (mU/mL) 60.7 ± 37.0 53.8 ± 28.4 0.5519
120-min IRI (mU/mL) 53.7 ± 33.1 51.6 ± 30.4 0.6880
AUCPG (mg$h/dL) 227.3 ± 33.4 231.5 ± 30.2 0.6078
AUCIRI (mU$h/mL) 90.5 ± 48.8 82.7 ± 41.4 0.4349
HOMA-IR 1.26 ± 0.71 1.30 ± 0.77 0.9585
HOMA-b (%) 100.7 ± 89.8 108.1 ± 62.7 0.3154
QUICKI 0.381 ± 0.035 0.379 ± 0.033 0.9585
AUCPG/AUCIRI 3.28 ± 1.99 3.45 ± 1.74 0.1931
AUC ¼ area under the curve; BMI ¼ body mass index; GCT ¼ glucose challenge test;
GTT ¼ glucose tolerance test; HOMA-b ¼ homeostasis model assessment for b-cell
function; HOMA-IR ¼ homeostasis model assessment for insulin resistance;
IRI ¼ immunoreactive insulin; PG ¼ plasma glucose; QUICKI ¼ quantitative insulin
sensitivity check index; SD ¼ standard deviation.
*p < 0.01.
**p < 0.05.
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trimester. In addition, the fraction of infants with birth weight 
3500 g in the 62 womenwas similar to that in the general Japanese
population: 9.7% (6/62) in this study versus 10.7% (112773/
1050806) in infants born in 2011 in Japan [5].
Although the IADPSG recommends 75gGTT at GW 24e28 for all
women not previously found to have overt diabetes or GDM in
testing performed earlier in the current pregnancy, [4] the Japanese
guidelines [1] recommend screening with 50gGCT (or measure-
ment of random PG) before the conﬁrming test (75gGTT) in such
women at GW 24e28. This was based on the following screening
characteristics of 50gGCT for detecting GDM according to the pre-
vious criteria [6] used in Japan: 50gGCT at GW 24e28 yielded a
sensitivity of 87.0%, speciﬁcity of 86.5%, and positive and negative
predictive values of 14.0% and 99.6%, respectively, among 902 un-
selected Japanese women, thus reducing the number of women
requiring 75gGTT. [7] Sugiyama et al [7] reported a positive rate of
15.4% in 50gGCT among unselected Japanese women. The positive
rate of 50gGCT was 33.9% (21/62) in the present study, which was
somewhat higher than this previous value of 15.4%, but may be
reasonable as our participants were at high risk of GDMwith a high
random PG level  105 mg/dL in the ﬁrst trimester. The criteria
adopted in 2010 [1] allow diagnosis of GDM in women with milder
glucose intolerance compared with the previous criteria, [5] thus
increasing the number of cases of GDM. [8] Therefore, the lack of
GDM patients after 75gGTT among the 21 women with a positive
result on 50gGCTwas unexpected, as we predictedmore than three
patients with GDM (14% of 21 women) based on the previous
positive predictive value of 14%. [7] This again suggested that Jap-
anese women shown to be normoglycemic on ﬁrst-trimester
75gGTT were unlikely to later develop GDM compared with unse-
lected Japanese women.
However, in a study of 163 Hungarian women with various risk
factors, such as obesity, family history of type 2 diabetes, and a
history of a large infant  4000 g, [9] the cumulative number of
patients with GDM increased with advancing gestation; GDM was
diagnosed in eight of the 163women after 75gGTTat GW < 16, in 32
(BMI, 28.4 ± 7.3) of the remaining 155 with normoglycemia on
75gGTT at GW < 16, but after 75gGTT at GW 24e28, and in 48 (BMI,
27.8 ± 5.9) of the remaining 123 with normoglycemia on the
75gGTT at GW 24e28, but after 75gGTT at GW 32e34. [9] Although
criteria for GDM diagnosis, ethnicity, and BMI of study participants
differed between this previous study performed in Hungary [9] and
the present study, these phenomena are well known; GDM is
manifested most often in the third trimester, [10,11] as pregnancy
fosters a state of insulin resistance with advancing gestation
[12e15] as observed in this study; and the 21 women who under-
went 75gGTT twice in the ﬁrst and second trimesters showed sig-
niﬁcant increases in HOMA-IR and HOMA-b, and a decrease in
QUICKI in the absence of signiﬁcant changes in PG level. However,
prepregnancy BMI is a very strong risk factor for GDM among
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tenfold higher in obese women (BMI  25) compared with lean
women (BMI < 18.5) in any age group. [16] Therefore, we may be
able to reduce the number of women who require screening for
GDM in the second trimester using a certain prepregnancy BMI cut-
off level among normoglycemic Japanesewomen on 75gGTT during
the ﬁrst trimester.
As mentioned above, 50gGCT is a useful tool for detection of
women at risk of GDM among unselected women [7] and a positive
test result (> 140 mg/dL) is an independent predictor of adverse
pregnancy outcome [17]; in 809womenwith a positive 50gGCTand
negative 100gGTT, the odds ratios (95% conﬁdence intervals) were
2.0 (1.5e2.7) for macrosomia, 1.6 (1.3e2.0) for large for gestational
age infant, 1.3 (1.1e1.6) for cesarean section, 1.6 (1.1e2.7) for
neonatal respiratory morbidity, and 1.8 (1.1e3.2) for neonatal hy-
poglycemia. [17] However, the present study indicated that second-
trimester 50gGCT results were not associated with ﬁrst-trimester
status of glucose tolerance, because neither the random PG levels
nor the 75gGTT results during the ﬁrst trimester differed between
the two groups divided according to the second-trimester 50gGCT
results. These observations support the our understanding that
some women with normal glucose metabolism develop GDM due
to failure of b-cell adaptation to pregnancy in which a gradual in-
crease in insulin resistance occurs [14,15].
In conclusion, the present study in a relatively small cohort
indicated that the risk of GDM was < 1/62 among Japanese women
with normoglycemia diagnosed on ﬁrst-trimester 75gGTT. Pre-
pregnancy BMI is a very strong risk factor for Japanese women [16].
Among women shown to be normoglycemic on ﬁrst-trimester
75gGTT, the use of a certain cut-off prepregnancy BMI level may
reduce the number of women requiring second-trimester screening
for GDM.
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